Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
Abstract This report summarizes the proceedings for day 2 sessions 1 and 3 of the 2‐day public workshop entitled "Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches," a jointly sponsored workshop by the US Food and Drug Administration (FDA) and the...
Saved in:
Main Authors: | Fang Wu (Author), Youssef Mousa (Author), Kimberly Raines (Author), Chris Bode (Author), Yu Chung Tsang (Author), Rodrigo Cristofoletti (Author), Hongling Zhang (Author), Tycho Heimbach (Author), Lanyan Fang (Author), Filippos Kesisoglou (Author), Amitava Mitra (Author), James Polli (Author), Myong‐Jin Kim (Author), Jianghong Fan (Author), Banu S. Zolnik (Author), Duxin Sun (Author), Yi Zhang (Author), Liang Zhao (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop
by: Yuqing Gong, et al.
Published: (2023) -
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview
by: Andrew Babiskin, et al.
Published: (2023) -
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
by: Abdullah Al Shoyaib, et al.
Published: (2023) -
Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery
by: Miyoung Yoon, et al.
Published: (2023) -
Development and comparison of model‐integrated evidence approaches for bioequivalence studies with pharmacokinetic end points
by: Xiaomei Chen, et al.
Published: (2024)